Latest News
New Drugs and Therapeutics Update: Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D)
Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D) Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta,…
Featured Resources
You can now purchase access to the all the Board Review Course materials:
-
- Access to video files that capture the audio recordings of lectures, synchronized to the images of the slides presented.
-
- Full color pdf of all slides plus and any supplemental information from speakers that was not covered during the presentation.
You can watch the videos on your own time - and as many times as you need.

